Prevalence of anti-SARS-CoV-2 antibody in hemodialysis facilities: a cross-sectional multicenter study from Madinah

BACKGROUND: Since the occurrence of coronavirus disease in 2019 (COVID-19), the global community has witnessed its exponential spread with devastating outcomes within the general population and specifically within hemodialysis patients. OBJECTIVES: Compare the state of immunity to SARS-CoV-2 among h...

Descripción completa

Detalles Bibliográficos
Autores principales: Housawi, Abdulrahman A., Qazi, Shazada Junaid S., Jan, Abdulhalem A., Osman, Rashid A., Alshamrani, Mashil M., AlFaadhel, Talal A., AlHejaili, Fayez F., Al-Tawfiq, Jaffar A., Wafa, Ahmed A., Hamza, Abdulmageed E., Hassan, Moustafa A., Alharbi, Suliman A., Albasheer, Hamza, Almohmmdi, Majed M., Alsisi, Salem A., Mankowski, Michal, Van de Klundert, Joris, Alhelal, Amal M., Sala, Fatima H., Kheyami, Ali, Alhomayeed, Bader A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Faisal Specialist Hospital and Research Centre 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357293/
https://www.ncbi.nlm.nih.gov/pubmed/35933611
http://dx.doi.org/10.5144/0256-4947.2022.229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357293/
https://www.ncbi.nlm.nih.gov/pubmed/35933611
http://dx.doi.org/10.5144/0256-4947.2022.229

Ejemplares similares